SCHEMBL7303011

SCHEMBL7303011

O=C(N[C@@H](Cc1ccccc1)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1)OCc1cccnc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 5/20 0.63
CTRB1 P17538 2/20 0.54
TRPM8 Q7Z2W7 1/20 0.47
CTSB P07858 3/20 0.47
NAMPT P43490 1/20 0.46
CTSL P07711 2/20 0.46
KMT2A Q03164 2/20 0.45
TACR1 P25103 2/20 0.45
MEN1 O00255 1/20 0.45
SLC22A2 O15244 1/20 0.45
SLC22A1 O15245 1/20 0.45
ABCC3 O15438 1/20 0.45
ABCC4 O15439 1/20 0.45
MLNR O43193 1/20 0.45
NR1I2 O75469 1/20 0.45
SLCO2B1 O94956 1/20 0.45
ABCB11 O95342 1/20 0.45
ALDH1A1 P00352 1/20 0.45
PGR P06401 1/20 0.45
ABCB1 P08183 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7305488 1.00 CYP3A4 (0.63) CYP3A4CTRB1TRPM8CTSBNAMPT
SCHEMBL7569915 1.00 CYP3A4 (0.63) CYP3A4CTRB1TRPM8CTSBNAMPT
SCHEMBL7357618 0.99 CYP3A4 (0.64) CYP3A4CTRB1TRPM8CTSBNAMPT
SCHEMBL7311171 0.91 CYP3A4 (0.59) CYP3A4CTSBCTSL
SCHEMBL7305834 0.91 CYP3A4 (0.59) CYP3A4CTSBCTSL
SCHEMBL7565435 0.91 CYP3A4 (0.59) CYP3A4CTSBCTSL
SCHEMBL8606231 0.91 CYP3A4 (0.55) CYP3A4CTRB1CTSBNAMPTCTSL
SCHEMBL7311195 0.91 CYP3A4 (0.55) CYP3A4CTRB1CTSBNAMPTCTSL
SCHEMBL7337249 0.91 CYP3A4 (0.55) CYP3A4CTRB1CTSBNAMPTCTSL
SCHEMBL7303656 0.90 CTRB1 (0.57) CYP3A4CTRB1TRPM8CTSBCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0486948-B1 Retroviral protease inhibiting compounds ABBOTT LAB (US) 2000-10-04 EP disclosed
EP-0997459-A1 Intermediates for preparing retroviral protease inhibiting compounds Abbott Laboratories (US) 2000-05-03 EP disclosed
US-5837873-A PROTECTED OXYDIAMINES ABBOTT LABORATORIES (US) 1998-11-17 US disclosed
US-5648497-A Retroviral protease inhibiting compounds ABBOTT LABORAOTRIES (US) 1997-07-15 US disclosed
US-5616714-A PYRIDYL, THIAZOLYL-SUBSTITUTED AMINO ACID DERIVATIVES ABBOTT LABORATORIES (US) 1997-04-01 US disclosed
US-5554783-A (2R, 3R, 4S, 5S)-3-ACETOXY-2,5-BIS/BENZYLOXYCARBONYLAMINO/ -4-BROMO-1,5-DIPHENYLHEXANE ABBOTT LABORATORIES (US) 1996-09-10 US disclosed
US-5354866-A Treating HIV infections ABBOTT LABORATORIES (US) 1994-10-11 US disclosed
EP-0486948-A2 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1992-05-27 EP disclosed